false 0001144215 0001144215 2026-11-19 2026-11-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 19, 2026

 

 

 

ACUITY INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware 001-16583 58-2632672
(State or other jurisdiction of
incorporation)
(Commission File Number) (IRS. Employer
Identification No.)

 

1170 Peachtree Street, N.E., Suite 1200, Atlanta, Georgia 30309

(Address of principal executive offices) (Zip Code)

 

(404) 853-1400

(Registrant’s telephone number, including area code)

 

None

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $.01 par value per share   AYI   New York Stock Exchange

 

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement

 

On November 19, 2026, Acuity Inc. (“we,” “our,” “us,” “the Company,” or similar references) entered into an Amendment No. 1 (the “Credit Facility Amendment”) to that certain Credit Agreement, dated as of May 8, 2026, among the Company, the subsidiary borrowers from time to time party thereto, the various lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent (the “Existing Credit Agreement”; the Existing Credit Agreement, as amended by the Credit Facility Amendment is referred to herein as the “Credit Agreement”).

 

The Credit Facility Amendment, among other things, provides for an unsecured delayed draw term loan facility of up to $400 million (the “Term Loan Facility”). The Credit Agreement permits the proceeds of the Term Loan Facility to be used for general corporate purposes, including to pay a portion of the cash consideration to close the acquisition of Parameter Technologies by Acuity Intelligent Spaces US Inc., a wholly owned subsidiary of the Company (the “Acquisition”), at a later date, and to pay fees, premiums, expenses and other transaction costs incurred in connection with the Acquisition. The Term Loan Facility may be drawn in a single borrowing, subject to certain conditions, at any time through the earliest of (i) the date that is six months after the effective date of the Credit Facility Amendment, (ii) the “outside date” (as defined in the definitive acquisition agreement for the Acquisition as in effect on the signing date thereof, giving effect to any extension thereto pursuant to the terms of such definitive acquisition agreement as in effect on the signing date thereof) and (iii) the date of the termination of the Term Loan Facility commitments in accordance with the Credit Agreement. On November 19, 2026, no loans were outstanding under the Term Loan Facility.

 

The Term Loan Facility will mature on May 8, 2031, which is the maturity date of the revolving loans and commitments under the Existing Credit Agreement. Borrowings under the Term Loan Facility bear interest at a rate equal to an adjusted base rate or Term SOFR, plus, in each case, an applicable margin. The applicable margin is based on, at the Company’s option, the Company’s leverage ratio or credit rating level. Undrawn commitments under the Term Loan Facility will accrue a facility fee from and including the date that is 91 days after the effective date of the Credit Facility Amendment, which facility fee will be determined, at the Company’s option, by the Company’s leverage ratio or credit rating level.

 

The covenants and events of default that apply to the revolving loans and commitments under the Credit Agreement also apply to the Term Loan Facility, and borrowings under the Term Loan Facility are guaranteed by the subsidiaries of the Company that guarantee the revolving loans and commitments.

 

The foregoing summary of the Credit Facility Amendment, including the transactions contemplated thereby, does not purport to be complete and is qualified in its entirety by reference to the full text of the Credit Facility Amendment, filed herewith as Exhibit 10.1 and incorporated herein by reference.

 

Item  2.03. Creation of a Direct Financial Obligation

 

The information set forth in Item 1.01 is incorporated by reference into this Item 2.03.

 

Item 9.01. Financial Statements and Exhibits.

 

(d)       Exhibits. The following exhibits are being filed herewith:

 

10.1 Amendment No. 1 to Credit Agreement, dated as of November 19, 2026, among Acuity Inc., the lenders party thereto, and JPMorgan Chase Bank, N.A., as administrative agent.
   
104 Cover Page Interactive Data File (embedded within the inline XBRL document).

 

 

 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 20, 2026

 

  ACUITY INC.
     
  By: /s/ Karen J. Holcom
    Karen J. Holcom
    Senior Vice President and Chief Financial Officer